Global  

BioPorto and University of Southern Denmark make progress on 10-minute coronavirus test

Proactive Investors Thursday, 17 September 2020
BioPorto Diagnostics A/S (CPH:BIOPOR) said its fast-track collaboration with the University of Southern Denmark (SDU) to create a 10-minute test for the coronavirus (COVID-19) has yielded promising results in tests against heat-inactivated virus. The collaboration, announced in April, leverages SDU’s antibody expertise and BioPorto’s Generic Rapid Assay Device (gRAD) platform for the development of lateral flow assays to develop a non-invasive rapid test for SARS-CoV-2, the virus that causes COVID-19.  The SARS-CoV-2 antibodies are highly specific to the virus’s spike protein, which could result in a higher clinical specificity compared to other commercially available rapid tests. READ: BioPorto sees revenue from its NGAL kidney test nearly double in second-quarter 2020 In the coming months, BioPorto plans to perfect the test using different sample types from known-positive patients. If successful, the company intends to request an Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) and to apply for a CE Mark in Europe, which could lead to a product launch before the end of the year. “The expedited development of a gRAD-based COVID-19 test and our promising analytical results have been very encouraging,” CEO Peter Eriksen said in a statement. “In a short time, we have been able to develop a test and bring it to the clinical evaluation stage. If we achieve our goals, the new COVID test, for the detection of the active virus, will demonstrate the value of our gRAD platform for fast and flexible creation of lateral flow assays, but more importantly, it could help make a real difference in global efforts to slow the virus through broad-based testing.” Looking ahead, BioPorto maintained its financial guidance for 2020, projecting full-year revenue of approximately DKK 30 million (US$4.8 million). The company expects an operating loss of approximately DKK 73 million (US$11.7 million). Contact Andrew Kessel at [email protected] Follow him on Twitter @andrew_kessel
0
shares
ShareTweetSavePostSend
 
Video Credit: PA - Press Association STUDIO - Published
News video: Coronavirus test chief Baroness Harding denies system is failing as pressure mounts

Coronavirus test chief Baroness Harding denies system is failing as pressure mounts 01:41

As pressure continued to mount on the Government over the chaos in the testingsystem, Baroness Harding – head of NHS Test and Trace – acknowledged thatdemand was outstripping capacity as she was questioned by the Science andTechnology Committee.

You Might Like


Related videos from verified sources

KU professor creating at-home rapid COVID-19 test [Video]

KU professor creating at-home rapid COVID-19 test

A University of Kansas professor and his graduate students are leading the way on an at-home COVID-19 test.

Credit: 41 Action News     Duration: 01:42Published
New rapid antigen test: Key questions answered [Video]

New rapid antigen test: Key questions answered

A new form of Covid-19 test which can produce results in just 15-30 minutes isset to be rolled out across the globe. Here, we look at some of the keyquestions surrounding the rapid antigen tests.The..

Credit: PA - Press Association STUDIO     Duration: 03:11Published
Nicola Sturgeon: Students not at fault for surging coronavirus cases [Video]

Nicola Sturgeon: Students not at fault for surging coronavirus cases

Nicola Sturgeon has insisted students are not to blame for a rise incoronavirus outbreaks, as she announced a record daily total of new Covid-19cases. Hundreds of students at universities across..

Credit: PA - Press Association STUDIO     Duration: 01:24Published